Billion Dollar Baby: Convergence Between Biotech and Pharma May Lead To Integrated Sector

ISSN： 1176-3469

Source： Pharmaceutical & Diagnostic Innovation, Vol.3, Iss.6, 2005-01, pp. : 3-5

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

The billion dollar price tag of obesity

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 620, 2011-01 ,pp. : 1-1

Adis International

Access to resources Recommend Favorite

Brazil saved $US1 billion between 2001 and 2005 due to its government's policy of bargaining with pharma companies over the cost of antiretrovirals

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 542, 2007-01 ,pp. : 11-11

Adis International

Access to resources Recommend Favorite

Strategies for reliable and effective ADME. Advice on a cost-effective strategy for Pharma and Biotech

Expert Opinion on Drug Safety, Vol. 3, Iss. 2, 2004-03 ,pp. : 85-87

Informa Healthcare

Access to resources Recommend Favorite

Pharma may adopt orphans to stimulate revenue

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 568, 2008-01 ,pp. : 3-3

Adis International

Access to resources Recommend Favorite

Prescribing by psychologists may benefit pharma industry

PharmacoEconomics and Outcomes News, Vol. 1, Iss. 383, 2002-01 ,pp. : 4-4

Adis International

Access to resources Recommend Favorite